EH
PFE icon

Equitable Holdings’s Pfizer PFE Stock Holding History

Equitable Holdings’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.89M Sell
203,198
-93,805
-32% -$2.45M 0.03% 467
2026
Q1 		$7.74M Buy
297,003
+100,098
+51% +$2.66M 0.05% 324
2025
Q4 		$4.9M Sell
196,905
-7,453
-4% -$188K 0.03% 383
2025
Q3 		$5.21M Buy
204,358
+23,128
+13% +$571K 0.04% 341
2025
Q2 		$4.39M Sell
181,230
-10,669
-6% -$249K 0.04% 359
2025
Q1 		$4.86M Buy
191,899
+11,198
+6% +$293K 0.05% 297
2024
Q4 		$4.79M Sell
180,701
-18,524
-9% -$502K 0.05% 286
2024
Q3 		$5.77M Buy
199,225
+9,708
+5% +$283K 0.06% 255
2024
Q2 		$5.3M Buy
189,517
+21,905
+13% +$603K 0.06% 254
2024
Q1 		$4.65M Sell
167,612
-17,152
-9% -$476K 0.05% 255
2023
Q4 		$5.32M Buy
184,764
+19,708
+12% +$596K 0.07% 213
2023
Q3 		$5.47M Buy
165,056
+14,264
+9% +$504K 0.08% 190
2023
Q2 		$5.53M Buy
150,792
+18,962
+14% +$738K 0.08% 174
2023
Q1 		$5.38M Buy
131,830
+71,626
+119% +$3.09M 0.09% 165
2022
Q4 		$3.08M Sell
60,204
-38,245
-39% -$1.83M 0.05% 232
2022
Q3 		$4.31M Buy
98,449
+7,405
+8% +$360K 0.08% 166
2022
Q2 		$4.77M Sell
91,044
-2,647
-3% -$135K 0.09% 149
2022
Q1 		$4.85M Sell
93,691
-3,742
-4% -$194K 0.08% 160
2021
Q4 		$5.75M Sell
97,433
-2,623
-3% -$130K 0.09% 149
2021
Q3 		$4.3M Buy
100,056
+14,743
+17% +$653K 0.07% 166
2021
Q2 		$3.34M Sell
85,313
-8,219
-9% -$320K 0.06% 186
2021
Q1 		$3.39M Sell
93,532
-5,411
-5% -$192K 0.07% 170
2020
Q4 		$3.64M Sell
98,943
-2,131
-2% -$78.2K 0.08% 151
2020
Q3 		$3.52M Buy
101,074
+10,001
+11% +$351K 0.09% 137
2020
Q2 		$2.83M Buy
91,073
+50,085
+122% +$1.7M 0.08% 150
2020
Q1 		$1.27M Buy
40,988
+1,622
+4% +$55.3K 0.05% 231
2019
Q4 		$1.46M Buy
+39,366
New +$1.4M 0.04% 242

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Equitable Holdings's PFE Position: Q2 2026 in Review

Equitable Holdings reduced its Pfizer (PFE) stake by 32% in Q2 2026, selling an estimated $2.45M and leaving 203,198 shares worth $4.89M. The position accounts for 0.03% of the portfolio, ranked #467.

Equitable Holdings first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.74M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Equitable Holdings held 203,198 shares of Pfizer worth $4.89M as of Q2 2026.
  • Equitable Holdings sold 93,805 Pfizer shares in Q2 2026, an estimated $2.45M.
  • Pfizer made up 0.03% of Equitable Holdings's portfolio in Q2 2026, its #467 holding.
  • Equitable Holdings first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Equitable Holdings's Pfizer position peaked at $7.74M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.